Human papillomavirus infection and pathogenesis in urothelial cells: A mini-review

Journal of Infection and Chemotherapy

Volumn 20, Issue 12, 2014, Pages 741-747

  Shigehara, Kazuyoshi ^a   Sasagawa, Toshiyuki ^b   Namiki, Mikio ^c  

^a ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

Bladder carcinoma; Human papillomavirus; Urothelial cell

Indexed keywords

BLADDER CARCINOMA; CANCER RISK; HUMAN; PAPILLOMAVIRUS INFECTION; PREVALENCE; REVIEW; SEXUALLY TRANSMITTED DISEASE; URETHRA DISEASE; UROTHELIUM; VIRUS CELL TRANSFORMATION; VIRUS PATHOGENESIS; VIRUS TYPING; BLADDER; BLADDER TUMOR; CYTOLOGY; EPITHELIUM CELL; ISOLATION AND PURIFICATION; PAPILLOMAVIRIDAE; PATHOLOGY; VIROLOGY;

EPITHELIAL CELLS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84940104460     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1016/j.jiac.2014.08.033     Document Type: Review

References (83)

1. Zur Hausen H. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res 1989;49:4677-81.
2. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008;43:S5-25.
3. Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: a systematic review of the literature. J Infect Dis 2006;194:1044-57.
4. Shigehara K, Sasagawa T, Kawaguchi S, Kobori Y, Nakashima T, Shimamura M, et al. High prevalence of human papillomavirus infection in the urinary tract in men with urethritis. Int J Urol 2010;17:563-8.
5. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;14:24-35.
6. Rubin MA, Kleter B, Zhou M, Ayala G, Cubilla AL, Quint WG, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001;159:1211-8.
7. Ouhoummane N, Steben M, Coutlée F, Vuong T, Forest P, Rodier C, et al. Squamous anal cancer: patient characteristics and HPV type distribution. Cancer Epidemiol 2013;37:807-12.
8. Zur Hausen H. Papillomavirus infectionsea major cause of human cancers. Biochim Biophys Acta 1996;1288:F55-78.
9. Giuliano AR, Nielson CM, Flores R, Dunne EF, Abrahamsen M, Papenfuss MR, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007;196:1146-52.
10. Nicolau SM, Camargo CG, Stávale JN, Castelo A, Dôres GB, Lörincz A, et al. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection. Urology 2005;65:251-5.
11. Lazcano-Ponce E, Herrero R, Muñoz N, Hernandez-Avila M, Salmerón J, Leyva A, et al. High prevalence of human papillomavirus infection in Mexican males: comparative study of penile-urethral swabs and urine samples. Sex Transm Dis 2001;28:277-80.
12. Kawaguchi S, Shigehara K, Sasagawa T, Shimamura M, Nakashima T, Sugimoto K, et al. Liquid-based urine cytology as a tool for detection of human papillomavirus, Mycoplasma spp., and Ureaplasma spp. in men. J Clin Microbiol 2012;50:401-6.
13. Nakashima K, Shigehara K, Kawaguchi S, Wakatsuki A, Kobori Y, Nakashima K, et al. Prevalence of human papillomavirus infection in the oropharynx and urine among sexually active men: a comparative study of infection by papillomavirus and other organisms, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma spp., and Ureaplasma spp. BMC Infect Dis 2014;14:43.
14. Shigehara K, Kawaguchi S, Sasagawa T, Furubayashi K, Shimamura M, Maeda Y, et al. Prevalence of genital Mycoplasma, Ureaplasma, Gardnerella, and human papillomavirus in Japanese men with urethritis, and risk factors for detection of urethral human papillomavirus infection. J Infect Chemother 2011;17:487-92.
15. Chrisofos M, Skolarikos A, Lazaris A, Bogris S, Deliveliotis Ch. HPV 16/18-associated condyloma acuminatum of the urinary bladder: first international report and review of literature. Int J STD AIDS 2004;15:836-8.
16. Karim RZ, Rose BR, Brammah S, Scolyer RA. Condylomata acuminata of the urinary bladder with HPV 11. Pathology 2005;37:176-8.
17. Kawaguchi S, ShigeharaK, Sasagawa T, KuribayashiM, Junicho A, Hasegawa T, et al. A case study of human papillomavirus-associated bladder carcinoma developing after urethral condyloma acuminatum. Jpn J Clin Oncol 2012;42:455-8.
18. Shigehara K, Sasagawa T, Kawaguchi S, Nakashima K, Nakashima T, Shimamura M, et al. Cytological evaluation using liquid-based cytology in the male urogenital tract infected with human papillomavirus. Diagn Cytopathol 2014;42:491-7.
19. Tena-Suck ML, Alarcón-Herrera A, Tirado-Sánchez A, Rösl F, Astudillo-de la Vega H. Male urethral pap smears and peniscopy examination and polymerase chain reaction human papillomavirus correlation. Diagn Cytopathol 2012;40:597-603.
20. Kitamura T, Yogo Y, Ueki T, Murakami S, Aso Y. Presence of human papillomavirus type 16 genome in bladder carcinoma in situ of a patient with mild immunodeficiency. Cancer Res 1988;48:7207-11.
21. Bryant P, Davies P, Wilson D. Detection of human papillomavirus DNA in cancer of the urinary bladder by in situ hybridisation. Br J Urol 1991;68: 49-52.
22. Kerley SW, Persons DL, Fishback JL. Human papillomavirus and carcinoma of the urinary bladder. Mod Pathol 1991;4:316-9.
23. Knowles MA. Human papillomavirus sequences are not detectable by Southern blotting or general primer-mediated polymerase chain reaction in transitional cell tumours of the bladder. Urol Res 1992;20:297-301.
24. Chetsanga C, Malmström PU, Gyllensten U, Moreno-Lopez J, Dinter Z, Pettersson U. Low incidence of human papillomavirus type 16 DNA in bladder tumor detected by the polymerase chain reaction. Cancer 1992;69:1208-11.
25. Shibutani YF, Schoenberg MP, Carpiniello VL, Malloy TR. Human papillomavirus associated with bladder cancer. Urology 1992;40:15-7.
26. Anwar K, Naiki H, Nakakuki K, Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 1992;70: 1967-73.
27. Yu ST, Wu MM, Li LM. Prevalence of human papillomaviruses 16 and 18 in transitional cell carcinoma of bladder. Chin Med J 1993;106:494-6.
28. Wilczynski SP, Oft M, Cook N, Liao SY, Iftner T. Human papillomavirus type 6 in squamous cell carcinoma of the bladder and cervix. Hum Pathol 1993;24: 96-102.
29. Sinclair AL, Nouri AM, Oliver RT, Sexton C, Dalgleish AG. Bladder and prostate cancer screening for human papillomavirus by polymerase chain reaction: conflicting results using different annealing temperatures. Br J Biomed Sci 1993;50:350-4.
30. Saltzstein DR, Orihuela E, Kocurek JN, Payne DA, Chan TS, Tyring SK. Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res 1993;13:423-5.
31. Furihata M, Inoue K, Ohtsuki Y, Hashimoto H, Terao N, Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res 1993;53:4823-7.
32. Mincione GP, Messerini L, Saltutti C, Di Cello V, Dominici A, Giannelli E, et al. HPV and p53 in urinary bladder carcinoma. Pathologica 1994;86:244-6.
33. Chang F, Lipponen P, Tervahauta A, Syrjänen S, Syrjänen K. Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridization and polymerase chain reaction. J Urol 1994;152:1429-33.
34. Aglianò AM, Gradilone A, Gazzaniga P, Napolitano M, Vercillo R, Albonici L, et al. High frequency of human papillomavirus detection in urinary bladder cancer. Urol Int 1994;53:125-9.
35. Maloney KE, Wiener JS, Walther PJ. Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. J Urol 1994;151:360-4.
36. Noel JC, Thiry L, Verhest A, Deschepper N, Peny MO, Sattar AA, et al. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 1994;44:671-5.
37. Kamel D, Pääkkö P, Pöllänen R, Vähäkangas K, Lehto VP, Soini Y. Human papillomavirus DNA and abnormal p53 expression in carcinoma of the urinary bladder. APMIS 1995;103:331-8.
38. Sano T, Sakurai S, Fukuda T, Nakajima T. Unsuccessful effort to detect human papillomavirus DNA in urinary bladder cancers by the polymerase chain reaction and in situ hybridization. Pathol Int 1995;45:506-12.
39. Kim KH, Kim YS. Analysis of p53 tumor suppressor gene mutations and human papillomavirus infection in human bladder cancers. Yonsei Med J 1995;36:322-31.
40. Smetana Z, Keller T, Leventon-Kriss S, Huszar M, Lindner A, Mitrani-Rosenbaum S, et al. Presence of human papilloma virus in transitional cell carcinoma in Jewish population in Israel. Cell Mol Biol (Noisy-le-grand) 1995;41:1017-23.
41. LaRue H, Simoneau M, Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin Cancer Res 1995;1:435-40.
42. Lopez-Beltran A, Muñoz E. Transitional cell carcinoma of the bladder: low incidence of human papillomavirus DNA detected by the polymerase chain reaction and in situ hybridization. Histopathology 1995;26:565-9.
43. Gopalkrishna V, Srivastava AN, Hedau S, Sharma JK, Das BC. Detection of human papillomavirus DNA sequences in cancer of the urinary bladder by in situ hybridisation and polymerase chain reaction. Genitourin Med 1995;71: 231-3.
44. Tenti P, Zappatore R, Romagnoli S, Civardi E, Giunta P, Scelsi R, et al. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J Pathol 1996;178:65-70.
45. Lopez-Beltran A, Escudero AL, Vicioso L, Muñoz E, Carrasco JC. Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br J Cancer 1996;73:124-7.
46. Mvula M, Iwasaka T, Iguchi A, Nakamura S, Masaki Z, Sugimori H. Do human papillomaviruses have a role in the pathogenesis of bladder carcinoma? J Urol 1996;155:471-4.
47. López-Beltrán A, Escudero AL, Carrasco-Aznar JC, Vicioso-Recio L. Human papillomavirus infection and transitional cell carcinoma of the bladder. Immunohistochemistry and in situ hybridization. Pathol Res Pract 1996;192: 154-9.
48. Boucher NR, Scholefield JH, Anderson JB. The aetiological significance of human papillomavirus in bladder cancer. Br J Urol 1996;78:866-9.
49. Lu QL, Lalaniel-N, Abel P. Human papillomavirus 16 and 18 infection is absent in urinary bladder carcinomas. Eur Urol 1997;31:428-32.
50. Cooper K, Haffajee Z, Taylor L. Human papillomavirus and schistosomiasis associated bladder cancer. Mol Pathol 1997;50:145-8.
51. Chan KW, Wong KY, Srivastava G. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction. J Clin Pathol 1997;50: 1018-21.
52. Aynaud O, Tranbaloc P, Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J Urol 1998;159: 86-9.
53. Gazzaniga P, Vercillo R, Gradilone A, Silvestri I, Gandini O, Napolitano M, et al. Prevalence of papillomavirus, Epstein-Barr virus, cytomegalovirus, and herpes simplex virus type 2 in urinary bladder cancer. J Med Virol 1998;55:262-7.
54. De Gaetani C, Ferrari G, Righi E, Bettelli S, Migaldi M, Ferrari P, et al. Detection of human papillomavirus DNA in urinary bladder carcinoma by in situ hybridization. J Clin Pathol 1999;52:103-6.
55. Simoneau M, LaRue H, Fradet Y. Low frequency of human papillomavirus infection in initial papillary bladder tumors. Urol Res 1999;27:180-4.
56. Tekin MI, Tuncer S, Aki FT, Bilen CY, Aygün C, Ozen H. Human papillomavirus associated with bladder carcinoma? Analysis by polymerase chain reaction. Int J Urol 1999;6:184-6.
57. Khaled HM, Raafat A, Mokhtar N, Zekri AR, Gaballah H. Human papilloma virus infection and overexpression of p53 protein in bilharzial bladder cancer. Tumori 2001;87:256-61.
58. Sur M, Cooper K, Allard U. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa. Pathology 2001;33:17-20.
59. Westenend PJ, Stoop JA, Hendriks JG. Human papillomaviruses 6/11, 16/18 and 31/33/51 are not associated with squamous cell carcinoma of the urinary bladder. BJU Int 2001;88:198-201.
60. Fioriti D, Pietropaolo V, Dal Forno S, Laurenti C, Chiarini F, Degener AM. Urothelial bladder carcinoma and viral infections: different association with human polyomaviruses and papillomaviruses. Int J Immunopathol Pharmacol 2003;16:283-8.
61. Khaled HM, Bahnassi AA, Zekri AR, Kassem HA, Mokhtar N. Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol Oncol 2003;21:334-41.
62. Barghi MR, Hajimohammadmehdiarbab A, Moghaddam SM, Kazemi B. Correlation between human papillomavirus infection and bladder transitional cell carcinoma. BMC Infect Dis 2005;5:102.
63. Youshya S, Purdie K, Breuer J, Proby C, Sheaf MT, Oliver RT, et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J Clin Pathol 2005;58:207-10.
64. Helal Tel A, Fadel MT, El-Sayed NK. Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors. Pathol Oncol Res 2006;12:173-8.
65. Moonen PM, Bakkers JM, Kiemeney LA, Schalken JA, Melchers WJ, Witjes JA. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur Urol 2007;52:464-8.
66. Badawi H, Ahmed H, Ismail A, Diab M, Moubarak M, Badawy A, et al. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J Med 2008;10:232.
67. Ben Selma W, Ziadi S, Ben Gacem R, Amara K, Ksiaa F, Hachana M, et al. Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients. Pathol Res Pract 2010;206:740-3.
68. Yavuzer D, Karadayi N, Salepci T, Baloglu H, Bilici A, Sakirahmet D. Role of human papillomavirus in the development of urothelial carcinoma. Med Oncol 2011;28:919-23.
69. Shigehara K, Sasagawa T, Kawaguchi S, Nakashima T, Shimamura M, Maeda Y, et al. Etiologic role of human papillomavirus infection in bladder carcinoma. Cancer 2011;117:2067-76.
70. Cai T, Mazzoli S, Meacci F, Nesi G, Geppetti P, Malossini G, et al. Human papillomavirus and non-muscle invasive urothelial bladder cancer: potential relationship from a pilot study. Oncol Rep 2011;25:485-9.
71. Polesel J, Gheit T, Talamini R, Shahzad N, Lenardon O, Sylla B, et al. Urinary human polyomavirus and papillomavirus infection and bladder cancer risk. Br J Cancer 2012;106:222-6.
72. Barghi MR, Rahjoo T, Borghei M, Hosseini-Moghaddam SM, Amani D, Farrokhi B. Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses. Arch Iran Med 2012;15:572-4.
73. Steinestel J, Cronauer MV, Müller J, Al Ghazal A, Skowronek P, Arndt A, et al. Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection. PLoS One 2013;8:e65189.
74. Berrada N, Al-Bouzidi A, Ameur A, Abbar M, El-Mzibri M, Ameziane-El-Hassani R, et al. Human papillomavirus detection in Moroccan patients with bladder cancer. J Infect Dev Ctries 2013;7:586-92.
75. Kim SH, Joung JY, Chung J, Park WS, Lee KH, Seo HK. Detection of human papillomavirus infection and p16 immunohistochemistry expression in bladder cancer with squamous differentiation. PLoS One 2014;9:e93525.
76. Li N, Yang L, Zhang Y, Zhao P, Zheng T, Dai M. Human papillomavirus infection and bladder cancer risk: a meta-analysis. J Infect Dis 2011;204:217-23.
77. Jimenez-Pacheco A, Exposito-Ruiz M, Arrabal-Polo MA, Lopez-Luque AJ. Metaanalysis of studies analyzing the role of human papillomavirus in the development of bladder carcinoma. Korean J Urol 2012;53:240-7.
78. O'Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 2012;48:1191-201.
79. Díaz De Ståhl T1, Segersten U, Malmström PU. Molecular genetics of bladder cancer: an update. Minerva Urol Nefrol 2008;60:205-16.
80. Rocco JW, Sidransky D. P16 (MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 2001;264:42-55.
81. Shai A, Brake T, Somoza C, Lambert PF. The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities. Cancer Res 2007;67:1626-35.
82. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
83. Shigehara K, Kawaguchi S, Sasagawa T, Nakashima K, Nakashima T, Shimamura M, et al. Etiological correlation of human papillomavirus infection in the development of female bladder tumor. APMIS 2013;121:1169-76.